Stratos Wealth Partners, Ltd. Grifols Sa Transaction History

Stratos Wealth Partners, Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 08, 2019	SELL	$17.44 - $21.53 $1,988 - $2,454	-114 Closed	0 $0
Q3 2018 Nov 02, 2018	BUY	$19.97 - $21.96 $2,276 - $2,503	114 New	114 $2,000
Q2 2018 Aug 13, 2018	SELL	$20.16 - $24.68 $29,171 - $35,711	-1,447 Closed	0 $0
Q1 2018 May 10, 2018	BUY	$20.31 - $24.95 $2,680 - $3,293	132 Added 10.04%	1,447 $31,000
Q4 2017 Feb 09, 2018	BUY	$20.99 - $23.89 $27,601 - $31,415	1,315	1,315 $30,000

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.33B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.